Vincerx Pharma, Inc. (VINC) Tops Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts VINC Hot Sheet
Join SI Premium – FREE
Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q2 EPS of ($0.05), $0.16 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Stripe, Advent In Talks To Buy Paypal - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
